Inventor
MAGID ABOU-GHARBIA
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations45%
C07DHeterocyclic compounds45%
A61KPreparations for medical, dental or toiletry purposes9%
PatentTitleYear
12,503,4585-hydroxytryptamine receptor 7 activity modulators and their method of use202512,269,8095-hydroxytryptamine receptor 7 activity modulators and their method of use202511,897,8705-hydroxytryptamine receptor 7 activity modulators and their method of use202411,787,794Aminothiazole compounds and methods using same202311,192,8715-hydroxytryptamine receptor 7 activity modulators and their method of use2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to UNIV TEMPLE (5)· patent assignee history
2021–2025Based in US· patent location history
2023Patents assigned to Temple University—Of the Commonwealth System of Higher Education (1)· patent assignee history
2024Patents assigned to TEMPLE UNIV OF THE COMMONWEALTH SYSTEM HIGHER EDUCATION (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEMPLE | 5 | 2021–2025 |
| TEMPLE UNIV OF THE COMMONWEALTH SYSTEM HIGHER EDUCATION | 1 | 2024 |
| Temple University—Of the Commonwealth System of Higher Education | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2025 |